In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases

Circulation Research

Volumn 79, Issue 3, 1996, Pages 541-550

  Strauss, Bradley H ^a   Robinson, Ranga ^a   Batchelor, Wayne B ^a   Chisholm, Robert J ^a   Ravi, Grama ^a   Natarajan, Madhu K ^a   Logan, Richard A ^a   Mehta, Shamir R ^a   Levy, Daniel E ^c   Ezrin, Alan M ^c   Keeley, Fred W ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Glycomed Inc   (United States)

Author keywords

angioplasty; collagen; gelatinase; matrix metalloproteinase; rabbit; restenosis

Indexed keywords

COLLAGEN; COLLAGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; ILIAC ARTERY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 9444236223     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.3.541     Document Type: Article

References (57)

1. Schwartz RS, Holmes DR, Topol EJ . The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:1284-1293.
2. Strauss BH, Chisholm RJ , Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
3. Karim MA, Miller DD, Farrar MA, Eleftheriades E, Reddy BH, Breland CM, Samarel AM. Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty. Circulation. 1995;91:2049-2057.
4. Bartos F, Ledvina M. Collagen, elastin and desmosines in three layers of bovine aortas of different ages. Exp Gerontol. 1979;14:21-26.
5. Hosoda Y, Kawano K, Yamasawa F, Ishii T, Shibata T, Inayama S. Age dependent changes of collagen and elastin content in human aorta and pulmonary artery. Angiology. 1984;35:615-621.
6. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis. 1986;6:585-593.
7. Katsuda S, Okada Y, Minamoto T, Oda Y, Matsui Y, Nakanishi I. Collagens in human atherosclerosis: immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb. 1992;12:494-502.
8. Eleftheriades EG, Durand J -B, Ferguson AG, Engelmann GL, J ones SB, Samarel AM. Regulation of procollagen metabolism in the pressure-overloaded rat heart. J Clin Invest. 1993;91:1113-1122.
9. Karim MA, Ferguson AG, Wakim BT, Samarel AM. In vivo collagen turnover during development of thyroxine-induce left ventricular hypertrophy. Am J Physiol. 1991;260:C316-C326.
10. Laurent GJ . Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol. 1987;252:C1-C9.
11. Raghow R, Thompson J P. Molecular mechanisms of collagen gene expression. Mol Cell Biochem. 1989;86:5-18.
12. Bishop J E, Guerreiro D, Laurent GJ . Changes in the composition and metabolism of arterial collagens during the development of pulmonary hypertension in rabbits. Am Rev Respir Dis. 1990;141:450-455.
13. Bienkowski RS. Intracellular degradation of newly synthesized collagen. Collagen Relat Res. 1984;4:399-412.
14. Rennard SI, Stier LE, Crystal RG. Intracellular degradation of newly synthesized collagen. J Invest Dermatol. 1982;79:77-822.
15. Woessner J F J r. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J . 1991;5:2145-2154.
16. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays. 1992;14:455-463.
17. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994;75:539-545.
18. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41-54.
19. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P, Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406.
20. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
21. Dollery CM, McEwan J R, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
22. Aimes RT, Quigley J P. Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem. 1995;270:5872-5876.
23. 3H] proline. Biochem J . 1982;206:535-544.
24. Peterkofsky B, Diegelman R. Use of a mixture of proteinase free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry. 1971;10:998-994.
25. 14C]hydroxyproline. Anal Biochem. 1975;66:330-339.
26. Brinckerhoff CE, Suzuki K, Mitchell TI, Oram F, Coon CI, Paliter RD, Nagase H. Rabbit procollagenase synthesized and secreted by a high-yield mammalian expression vector requires stromelysin (matrix metalloproteinase-3) for maximal activation. J Biol Chem. 1990;265:22262-22269.
27. Vater CA, Hahn J L, Harris ED J r. Preparation of a monospecific antibody to purified rabbit synovial fibroblast collagenase. Collagen Relat Res. 1981;1:527-542.
28. Cruz TF, Mills G, Pritzker KPH, Kandel RA. Inverse correlation between tyrosine phosphorylation and collagenase production in chondrocytes. Biochem J . 1990;269:717-721.
29. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
30. Galardy RE. Galardin™. Drugs Future. 1993;18:1109-1111.
31. Kivirikko KI, Laitenen O, Prockop DJ . Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967;19:249-255.
32. Strauss BH, van Suylen RJ , Umans VA, de Feyter PJ , Marco J , Robertson GC, Wijns W, Heyndrickx GR, Vuzevski VD, Bosman FT, Serruys PW. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histologie results. J Am Coll Cardiol. 1992;20:1465-1473.
33. Southgate KM, Davies M, Booth RF, Newby AC. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J . 1992;288:93-99.
34. Au YPT, Montgomery KF, Clowes AW. Heparin inhibits collagenase gene expression mediated by phorbol ester-responsive element in primate arterial smooth muscle cells. Circ Res. 1992;70:1062-1069.
35. Kishi J , Hayakawa T. Synthesis of latent collagenase and collagenase inhibitor by bovine aortic medial explants and cultured medial smooth muscle cells. Connect Tissue Res. 1989;19:63-76.
36. Scott-Herron G, Werb Z, Dwyer K, Banda MJ . Secretion of metalloproteinases by stimulated capillary endothelial cells, I: production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem. 1986;261:2810-2813.
37. Scott-Herron G, Banda J , Clark J , Gavrilovic J , Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells, II: expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem. 1986;261:2814-2818.
38. Calls ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
39. Clowes AW, Clowes MM, Au YPT, Reidy RA, Belin M. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990;67:61-67.
40. Forough R, Hastenstab D, Zempo N, Langley K, De Clerck Y, Clowes A. Induction of tissue inhibitor of metalloproteinase-2 in injured rat artery. Ann N Y Acad Sci. 1994;732:384-388.
41. Bendeck MP, Irvin C, Reidy MA. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res. 1996;78:38-43.
42. Ye C, Rabinovitch M. Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol. 1991;261:H1255-H1267.
43. Levy DE, Tang PC, Sweet K, Summers B, Lapierre F, Ezrin AM. A hydroxamic acid matrix metalloproteinase inhibitor blocks the activity of endothelin converting enzyme in anesthetized rats. Med Chem Res. 1994;4:547-553.
44. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S. Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;178:899-905.
45. Ikegawa RY, Matsumura Y, Tsukahara M, Takaoka M, Morimoto S. Phosphoramidon inhibits the generation of endothelin-1 from exogenously applied big endothelin-1 in cultured vascular endothelial cells and smooth muscle cells. FEBS Lett. 1991;293:45-48.
46. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade for restenosis: a special case of atherosclerosis progression. Circulation. 1992;86(suppl III):III-47-III-52.
47. Clausell N, de Lima VC, Molossi S, Liu P, Turley E, Gotlieb AI, Adelman AG, Rabinovitch M. Expression of tumour necrosis factor α and accumulation of fibronectin in coronary artery restenotic lesions retrieved by alherectomy. Br Heart J . 1995;73:534-539.
48. Kishikawa H, Shimokama T, Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima: role of cell-mediated immunity in human atherogenesis. Virchows Arch A Pathol Anat Histopathol. 1993;423:433-442.
49. Fleet J C, Clinton SK, Salomon RN, Loppnow H, Libby P. Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. J Nutr. 1992;122:294-305.
50. Nabel EG. Biology of the impaired endothelium. Am J Cardiol. 1991;68:6C-8C.
51. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today. 1989;10:370-375.
52. Gearing AJ H, Beckett P, Christodoulou M, Churchilll M. Clements J , Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon J L, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature. 1994;370:555-557.
53. McGeehan GM, Becherer J D, Bast RC J r, Boyer CM, Champion B, Connolly KM, Conway J G, Furdon P, Karp S, Kidao S, McElroy AB, Nichols J , Pryzwansky KM, Schoenen F, Sekut L, Truesdale A, Verghese M, Warner J , Ways J P. Regulation of tumour necrosis factor-α by a metalloproteinase inhibitor. Nature. 1994;370:558-561.
54. Mohler KM, Sleath PR, Fitzner J N, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, Kronhelm SR, Petersen M, Gerhart M, Koziosky CJ , March CJ , Black RA. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 1994;370:218-220.
55. Malone J D, Richards M, J effrey J J . Recruitment of peripheral mononuclear cells by mammalian collagenase digests type I collagen. Matrix. 1991;11:289-295.
56. Laskin DL, Kimura T, Sakaibara S, Riley DJ , Berg RA. Chemotactic activity of collagen-like polypeptides for human peripheral blood monocytes. J Leukoc Biol. 1986;39:255-266.
57. Albini A, Adelmann-Grill BC. Collagenolytic cleavage products of collagen type I as chemoattractants for human dermal fibroblasts. Eur J Cell Biol. 1985;36:104-107.